4-(1,3-benzothiazol-2-yl)-N-{[7-(cyclopropylmethyl)-8-oxo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl]methyl}butanamide
Chemical Structure Depiction of
4-(1,3-benzothiazol-2-yl)-N-{[7-(cyclopropylmethyl)-8-oxo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl]methyl}butanamide
4-(1,3-benzothiazol-2-yl)-N-{[7-(cyclopropylmethyl)-8-oxo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl]methyl}butanamide
Compound characteristics
| Compound ID: | SA19-0518 |
| Compound Name: | 4-(1,3-benzothiazol-2-yl)-N-{[7-(cyclopropylmethyl)-8-oxo-5,6,7,8-tetrahydroimidazo[1,2-a]pyrazin-2-yl]methyl}butanamide |
| Molecular Weight: | 423.54 |
| Molecular Formula: | C22 H25 N5 O2 S |
| Smiles: | C(CC(NCc1cn2CCN(CC3CC3)C(c2n1)=O)=O)Cc1nc2ccccc2s1 |
| Stereo: | ACHIRAL |
| logP: | 2.7096 |
| logD: | 2.7096 |
| logSw: | -2.9317 |
| Hydrogen bond acceptors count: | 6 |
| Hydrogen bond donors count: | 1 |
| Polar surface area: | 63.991 |
| InChI Key: | GTNCCSLVODAEQY-UHFFFAOYSA-N |